Jiyan Y. Liu
China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 82 publications
Impact of Adverse Childhood Experience on Lung Cancer Risk: A Population-Based Prospective Cohort Study.
Journal: Cancer control : journal of the Moffitt Cancer Center
Published: March 25, 2026
Evening circadian preference as a potential risk factor for cancer-depression comorbidity: a comprehensive analysis from population cohort to molecular insights.
Journal: Journal of advanced research
Published: December 27, 2025
SIRT3 regulates mitochondrial metabolism through deacetylation of SLC25A6 to impact gastric cancer progression and drug resistance.
Journal: Journal of translational medicine
Published: December 07, 2025
DC vaccine loaded with Bacteroides fragilis elicits functional cross-reactivity and enhances anti-PD-1 immunotherapy.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: November 09, 2025
Zoledronic acid enhances the antitumor efficacy of the PSMA CAR-T cells for bone tumors, but impedes the ability to control metastases of prostate cancer in mice.
Journal: Cancer gene therapy
Published: October 19, 2025
Histopathology images-based deep learning prediction of prognosis in primary mucinous ovarian carcinoma.
Journal: Frontiers in oncology
Published: September 12, 2025
Sintilimab Plus Axitinib for Advanced Fumarate Hydratase-Deficient Renal Cell Carcinoma: A Phase 2 Nonrandomized Clinical Trial.
Journal: JAMA oncology
Published: August 14, 2025
Circulating Plasma Proteins as Biomarkers for Immunotherapy Toxicity: Insights from Proteome-Wide Mendelian Randomization and Bioinformatics Analysis.
Journal: Biomedicines
Published: May 16, 2025
Natural Infection of Omicron BA.5.2 in Patients Provides Broad Immune Responses Against SARS-CoV-2.
Journal: Microorganisms
Published: March 13, 2025
Endoscopic Thulium Laser Ablation with Disitamab Vedotin and Immunotherapy in High-risk Upper Tract Urothelial Carcinoma: A Prospective Pilot Study of a Novel Kidney-sparing Strategy.
Journal: European urology oncology
Published: February 03, 2025
Raltitrexed, S-1 and fruquintinib (RSF) in the treatment of refractory metastatic colorectal cancer: study protocol for a multicenter, prospective, single-arm, phase II trial.
Journal: BMC cancer
Published: January 19, 2025
Last Updated: 09/26/2026